Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01721772
Brief Title: Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma (CheckMate 066)

First Submitted : November 2, 2012
First Submitted that Met QC Criteria : November 2, 2012
First Posted : November 6, 2012 (Estimate)

Results First Submitted : November 20, 2015
Results First Submitted that Met QC Criteria : January 27, 2016
Results First Posted : February 25, 2016 (Estimate)

Certification/Extension First Submitted : July 3, 2015
Certification/Extension First Submitted that Met QC Criteria : July 3, 2015
Certification/Extension First Posted : July 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 10, 2018
Last Update Posted : August 8, 2018